EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Engineering exosomes for targeted neurodegenerative therapy: innovations in biogenesis, drug loading, and clinical translation

Qinqin Huang, Shile Wang, Zeming Liu, Lang Rao, Ke Cheng, Xiaobo Mao

Theranostics · 2026

DOI: 10.7150/thno.117143 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Theranostics, 2026. Verfasst von Qinqin Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Electronic and Electrical Engineering, Wuhan Textile University, Wuhan 430200, China. Hauptthemen laut MEDLINE: Exosomes, Neurodegenerative Diseases, Drug Delivery Systems. Die Arbeit wurde bisher 42-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative diseases (NDDs), including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), Huntington's disease (HD) and multiple sclerosis (MS), are characterized by progressive neuronal dysfunction and limited therapeutic options, largely due to the restrictive nature of the blood-brain barrier (BBB). Exosomes, naturally occurring extracellular vesicles (EVs), have gained attention as innovative drug delivery vehicles owing to their intrinsic ability to cross the BBB, minimal immunogenicity, high biocompatibility, and capability to carry diverse therapeutic cargos such as proteins, nucleic acids, and small molecules. Furthermore, exosomes can be bioengineered to enhance drug-loading efficiency and targeting specificity, positioning them as a versatile and effective platform for treating NDDs. In this review, we summarize recent advances in exosome biogenesis, secretion, and engineering, with an emphasis on innovative strategies for exosome isolation, drug loading, and surface modification. We further explore their roles in modulating neuroinflammation, promoting neural regeneration, and enabling precise therapeutic delivery. Critical challenges associated with large-scale production, quality control, and regulatory compliance under Good Manufacturing Practices (GMP) are also discussed. Collectively, these developments underscore the transformative potential of engineered exosomes in advancing precision therapies for neurodegenerative disorders and offer strategic insights into their clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesNeurodegenerative DiseasesDrug Delivery SystemsHumansAnimalsBlood-Brain BarrierBioengineeringTranslational Research, Biomedical

Stichwörter der Autor:innen

blood-brain barrier (BBB)clinical trialsdrug deliveryexosomesneurodegenerative diseases (NDDs)targeted therapy

Autor:innen und Institutionen

  • School of Electronic and Electrical Engineering, Wuhan Textile University, Wuhan 430200, China.
  • Department of Plastic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
  • Institute of Chemical Biology, Shenzhen Bay Laboratory, Shenzhen 518132, China.
  • Department of Biomedical Engineering, Columbia University, New York 10027, USA.
  • Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  • Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

Zitieren

APA

Huang, Q., Wang, S., Liu, Z., Rao, L., Cheng, K., & Mao, X. (2026). Engineering exosomes for targeted neurodegenerative therapy: innovations in biogenesis, drug loading, and clinical translation. Theranostics. https://doi.org/10.7150/thno.117143

Vancouver

Huang Q, Wang S, Liu Z, Rao L, Cheng K, Mao X. Engineering exosomes for targeted neurodegenerative therapy: innovations in biogenesis, drug loading, and clinical translation. Theranostics. 2026. doi:10.7150/thno.117143

BibTeX
@article{Huang2026,
  author = {Huang, Qinqin and Wang, Shile and Liu, Zeming and Rao, Lang and Cheng, Ke and Mao, Xiaobo},
  title = {Engineering exosomes for targeted neurodegenerative therapy: innovations in biogenesis, drug loading, and clinical translation},
  journal = {Theranostics},
  year = {2026},
  doi = {10.7150/thno.117143}
}
Kostenlos starten →